Reference
1. Yang J,Zheng Y,Gou X, et al.
Prevalence of comorbidities and its effects in patients infected with
SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis,
2020. 94: 91-95.
2. Lu R,Zhao X,Li J, et al. Genomic
characterisation and epidemiology of 2019 novel coronavirus:
implications for virus origins and receptor binding. Lancet, 2020.
395(10224): 565-574.
3. Maan S,Maan N S,Nomikou K, et al.
Complete genome characterisation of a novel 26th bluetongue virus
serotype from Kuwait. PLoS One, 2011. 6(10): e26147.
4. Xu X,Chen P,Wang J, et al.
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and
modeling of its spike protein for risk of human transmission. Sci China
Life Sci, 2020. 63(3): 457-460.
5. Wang W,Tang J,Wei F. Updated
understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in
Wuhan, China. J Med Virol, 2020. 92(4): 441-447.
6. Merad M,Martin J C. Pathological
inflammation in patients with COVID-19: a key role for monocytes and
macrophages. Nat Rev Immunol, 2020. 20(6): 355-362.
7. Zhang Y,Bian S,Liu X, et al.
Positive Rate of Different Hepatitis B Virus Serological Markers in
Peking Union Medical College Hospital, a General Tertiary Hospital in
Beijing. Chin Med Sci J, 2016. 31(1): 17-12.
8. Wu Z,McGoogan J M. Characteristics
of and Important Lessons From the Coronavirus Disease 2019 (COVID-19)
Outbreak in China: Summary of a Report of 72314 Cases From the Chinese
Center for Disease Control and Prevention. JAMA, 2020.
9. Zabetakis I,Lordan R,Norton C, et
al. COVID-19: The Inflammation Link and the Role of Nutrition in
Potential Mitigation. Nutrients, 2020. 12(5).
10. Zhou M,Zhang X,Qu J. Coronavirus
disease 2019 (COVID-19): a clinical update. Front Med, 2020. 14(2):
126-135.
11. Wu C,Chen X,Cai Y, et al. Risk
Factors Associated With Acute Respiratory Distress Syndrome and Death in
Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA
Intern Med, 2020.
12. Ruan Q,Yang K,Wang W, et al.
Clinical predictors of mortality due to COVID-19 based on an analysis of
data of 150 patients from Wuhan, China. Intensive Care Med, 2020. 46(5):
846-848.
13. Zhou F,Yu T,Du R, et al. Clinical
course and risk factors for mortality of adult inpatients with COVID-19
in Wuhan, China: a retrospective cohort study. Lancet, 2020. 395(10229):
1054-1062.
14. Bourgonje A R,Abdulle A E,Timens
W, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the
pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol, 2020.
15. Cheng Y,Luo R,Wang K, et al.
Kidney disease is associated with in-hospital death of patients with
COVID-19. Kidney Int, 2020. 97(5): 829-838.
16. Caccialanza R,Laviano A,Lobascio
F, et al. Early nutritional supplementation in non-critically ill
patients hospitalized for the 2019 novel coronavirus disease (COVID-19):
Rationale and feasibility of a shared pragmatic protocol. Nutrition,
2020. 74: 110835.